155 related articles for article (PubMed ID: 27052201)
1. The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.
Walcher S; Koc J; Reichel V; Schlote F; Verthein U; Reimer J
BMC Pharmacol Toxicol; 2016 Apr; 17():15. PubMed ID: 27052201
[TBL] [Abstract][Full Text] [Related]
2. When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.
Reimer J; Boniakowski E; Bachner C; Weber B; Tietje W; Verthein U; Walcher S
Subst Abuse Treat Prev Policy; 2014 Feb; 9():13. PubMed ID: 24581310
[TBL] [Abstract][Full Text] [Related]
3. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.
González-Saiz F; Lozano Rojas O; Trujols J; Alcaraz S; Siñol N; Pérez de Los Cobos J;
Drug Alcohol Depend; 2018 Feb; 183():127-133. PubMed ID: 29247974
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of buprenorphine dosage adequacy in opioid receptor agonist substitution therapy for heroin dependence: first use of the BUprenorphine-naloxone Dosage Adequacy eVAluation (BUDAVA) questionnaire.
D'Amore A; Romano F; Biancolillo V; Lauro G; Armenante C; Pizzirusso A; Del Tufo S; Ruoppolo C; Auriemma F; Cassese F; Oliva P; Amato P
Clin Drug Investig; 2012 Jul; 32(7):427-32. PubMed ID: 22559256
[TBL] [Abstract][Full Text] [Related]
5. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
[TBL] [Abstract][Full Text] [Related]
6. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
Verthein U; Haasen C; Reimer J
Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
Chang KC; Huang CL; Liang HY; Chang SS; Wang YC; Liang WM; Lane HY; Chen CH; Stephen Huang SK
J Cardiovasc Electrophysiol; 2012 May; 23(5):527-33. PubMed ID: 22136144
[TBL] [Abstract][Full Text] [Related]
8. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
[TBL] [Abstract][Full Text] [Related]
9. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
10. Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China.
Xia Y; Zhang D; Li X; Chen W; He Q; Jahn HJ; Li X; Chen J; Hu P; Ling L
Psychol Health Med; 2013; 18(3):321-9. PubMed ID: 23092392
[TBL] [Abstract][Full Text] [Related]
11. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addicted patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation.
D'Egidio PF; Bignamini E; De Vivo E; Leonardi C; Pieri MC; González-Saiz F; Lucchini A;
Subst Use Misuse; 2013 Dec; 48(14):1530-40. PubMed ID: 23822738
[TBL] [Abstract][Full Text] [Related]
12. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in Haiphong, Vietnam.
Khue PM; Tham NT; Thanh Mai DT; Thuc PV; Thuc VM; Han PV; Lindan C
Harm Reduct J; 2017 Aug; 14(1):59. PubMed ID: 28854943
[TBL] [Abstract][Full Text] [Related]
14. Psychometric Characteristics of the Persian Version of the Opiate Dosage Adequacy Scale (ODAS).
Golnezhad A; Torkaman-Boutorabi A; Mohammad Razaghi E; Zarrindast MR; Yadollahi S; Dousti Kataj P; Vousooghi N
Basic Clin Neurosci; 2023; 14(4):471-478. PubMed ID: 38050570
[TBL] [Abstract][Full Text] [Related]
15. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
Nordmann S; Lions C; Vilotitch A; Michel L; Mora M; Spire B; Maradan G; Morel A; Roux P; Carrieri MP;
Psychopharmacology (Berl); 2016 Apr; 233(7):1203-13. PubMed ID: 26753792
[TBL] [Abstract][Full Text] [Related]
16. Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates.
Gerra G; Manfredini M; Somaini L; Maremmani I; Leonardi C; Donnini C
Eur Addict Res; 2016; 22(3):163-75. PubMed ID: 26595117
[TBL] [Abstract][Full Text] [Related]
17. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
[TBL] [Abstract][Full Text] [Related]
18. Effect of community-based extension clinics of methadone maintenance therapy for opiate-dependent clients: A prospective cohort study in Dehong Prefecture, Yunnan Province of China.
Zhang G; Yang Y; Ye R; Zhang D; Shan D; Hu Y; Dai B; Liu Z
Medicine (Baltimore); 2018 Nov; 97(47):e13323. PubMed ID: 30461647
[TBL] [Abstract][Full Text] [Related]
19. Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment.
Yee A; Danaee M; Loh HS; Sulaiman AH; Ng CG
PLoS One; 2016; 11(1):e0147852. PubMed ID: 26820154
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with one year retention to methadone maintenance treatment program among patients with heroin dependence in China.
Jiang H; Han Y; Du J; Wu F; Zhang R; Zhang H; Wang J; Zhou Z; Hser YI; Zhao M
Subst Abuse Treat Prev Policy; 2014 Feb; 9():11. PubMed ID: 24565169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
